Archive for the ‘Stages of Mesothelioma’ Category

Mesothelioma stages and staging system : Part – 4

Friday, November 27th, 2009

Brigham Staging System

It is the most recent staging system for mesothelioma and looks at variables such as lymph node status and tumor resectability (ability to surgically remove a tumor). The Brigham staging system consists of four stages:

Stage

Location

I

Resectable mesothelioma and no lymph node involvement

II

Resectable mesothelioma but with lymph node involvement

III

Unresectable mesothelioma extending into chest wall, heart, or through diaphragm, peritoneum; with or without extrathoracic lymph node involvement

IV

Distant metastatic disease

Mesothelioma stages and staging system : Part – 3

Thursday, November 26th, 2009

TNM Staging System

This system considers three components; the first letter of each forming the name of the system. Doctors using TNM will look at the tumor, lymph nodes, and whether the cancer has metastasized. Like the Butchart system, it is divided into four stages.

Stage

Location

T1a

Limited to ipsilateral parietal pleura (including mediastinal and diaphragmatic pleura), with no involvement of visceral pleura

T1b

Ipsilateral parietal pleura (including mediastinal and diaphragmatic pleura), with scattered foci of visceral pleural involvement

T2

Ipsilateral pleural surface has at least 1 of the following:

  • Diaphragmatic muscle involvement
  • Confluent visceral pleural tumor involvement (including fissures)
  • Extension from visceral pleura into pulmonary parenchyma

T3

Locally advanced but resectable tumor; each ipsilateral pleural surface has at least 1 of the following:

  • Involvement of the endothoracic fascia
  • Extension into the mediastinal fat
  • Solitary, completely resectable tumor focus in chest wall soft tissues
  • Nontransmural involvement of the pericardium

T4

Locally advanced, technically unresectable tumor; each ipsilateral pleural surface has at least 1 of the following:

  • Diffuse extension or multifocal chest wall masses with or without rib destruction
  • Direct transdiaphragmatic extension into the peritoneum
  • Direct extension to contralateral pleura
  • Direct extension to 1 or more mediastinal organs
  • Direct extension into spine
  • Extension through to internal surface of pericardium, with or without pericardial effusion or myocardial involvement

NX

Regional lymph nodes not assessable

N0

No regional lymph nodes metastases

N1

Metastases in ipsilateral bronchopulmonary or hilar lymph nodes

N2

Metastases in subcarinal or ipsilateral mediastinal lymph nodes, including ipsilateral internal mammary nodes

N3

Metastases in contralateral mediastinal, contralateral internal mammary, and ipsilateral or contralateral supraclavicular lymph nodes

MX

Distant metastases not assessable

M0

No distant metastases

M1

Distant metastases present

Mesothelioma stages and staging system : Part – 2

Wednesday, November 25th, 2009

An important aspect is that as pleural mesothelioma is the most common among all types of cancer and occurs frequently, these staging systems are devised to mark its stages.

The three established and recognized clinical staging systems for mesothelioma are:

  • The Butchart System
  • TNM Staging
  • The Brigham System

The Butchart Staging System:

Butchart is the oldest system and is still the most commonly used.  Its four stages are based on the extent of primary tumor mass.

Stage

Location

I

Tumor confined to the ipsilateral pleura, lung, or pericardium

II

Tumor invading the chest wall or mediastinal structures or metastases to thoracic lymph nodes

III

Tumor penetrating the diaphragm to involve the peritoneum or metastases to extrathoracic lymph nodes

IV

Distant blood-borne metastases

Mesothelioma stages and staging system : Part – 1

Friday, November 20th, 2009

Staging is the process of finding out how far the mesothelioma cancer has spread. Doctors determine which treatments to use based on the mesothelioma stage, or the severity of the disease. Staging of mesothelioma is based on imaging studies such as x-rays, CT scans, and MRI scans.

To keep a track of mesothelioma cancer, the extent of its spread and the size of tumor(s); mesothelioma has been divided into a few stages or staging systems. These mesothelioma staging systems keep a track of the development of cancer in the human body. The tests and scans when diagnosing cancer give some information about the stage. It is important because treatment is often decided according to the stage of a cancer.
Some elements common to most staging systems are:
• Location of the primary tumor.
• Size and number of the tumors.
• Lymph node involvement.
• Cell type and tumor grade.
• Metastasis.

Many cancer registries, such as the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (SEER) use summary staging, a system used for all types of cancer. Summary staging groups cancer into five main categories:

• In situ – cancer that is present only in the layer of cells in which it began.

• Localized – cancer that is limited to the organ in which it began with no evidence of spread.

• Regional – cancer that has spread from the primary site to nearby lymph nodes or organs.

• Distant – cancer that has spread from the primary site to distant lymph nodes or organs.

• Unknown – cases where not enough information exists to indicate stage.